Eiger BioPharmaceuticals, Inc. EIGR
Set alert
1.73 +1.73 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 2.55M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -0.48
- Beta
- 1.84
- Short ratio
- 3.72
- Inst. own
- 43.86%
- Dividend
- 0.00
- Ex-div date
- Earnings
- May 9, 2024
- 50-d avg
- 4.59
- 200-d avg
- 10.27
- 1y target
- 30.00
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 30.00
Ratings (0m) 6 6 buy · 0 hold · 0 sell
- Strong buy4
- Buy2
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 6
- 1 month ago 2
- 2 months ago 3
- 3 months ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -5.40 | -5.40 – -5.40 | -15.60 | +65.4% | 5.55M | +34.8% | 1 |
| Next quarter | -3.90 | -3.90 – -3.90 | -14.10 | +72.3% | 6.05M | +30.3% | 1 |
| Current year | -15.60 | -15.60 – -15.60 | -50.78 | +69.3% | 25.22M | +59.9% | 1 |
| Next year | -3.60 | -3.60 – -3.60 | -15.60 | +76.9% | 32.65M | +29.5% | 1 |